Status:

NOT_YET_RECRUITING

Diagnostic Access to Self-Care and Health Services in Low and Middle Income Countries (DASH) - Phase II

Lead Sponsor:

University of Washington

Collaborating Sponsors:

Kenya Medical Research Institute

Centre for Infectious Disease Research in Zambia

Conditions:

Malaria Infection

Pregnancy

Eligibility:

All Genders

6+ years

Phase:

NA

Brief Summary

Our primary goal is to determine if on-demand, home-based rapid testing, or rapid testing done by a community health worker (CHW) results in people testing for diseases more frequently and getting car...

Detailed Description

Our long-term objective is to evaluate the best use case scenarios and implementation of community-based rapid testing to enhance testing adoption and case detection, accelerate linkage to care and tr...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Resides in the household and has spent ≥1 night at the house in the prior four weeks
  • Plans to reside in the house for duration of the study
  • Willing and able to provide informed consent, assent, or parental consent (where needed)

Exclusion

    Key Trial Info

    Start Date :

    October 1 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2025

    Estimated Enrollment :

    2250 Patients enrolled

    Trial Details

    Trial ID

    NCT06588790

    Start Date

    October 1 2024

    End Date

    December 1 2025

    Last Update

    September 19 2024

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Kenya Medical Research Institute

    Kisumu, Kenya

    2

    Human Sciences Research Council

    Durban, South Africa

    3

    Center for Infectious Disease Research in Zambia

    Lusaka, Zambia